nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC18A2—telencephalic ventricle—autistic disorder	0.0515	0.162	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalic ventricle—autistic disorder	0.0389	0.123	CbGeAlD
Lisdexamfetamine—SLC6A3—hindbrain—autistic disorder	0.0184	0.0579	CbGeAlD
Lisdexamfetamine—SLC18A2—brainstem—autistic disorder	0.0139	0.0439	CbGeAlD
Lisdexamfetamine—SLC18A2—forebrain—autistic disorder	0.0134	0.0423	CbGeAlD
Lisdexamfetamine—SLC18A2—telencephalon—autistic disorder	0.0124	0.0389	CbGeAlD
Lisdexamfetamine—SLC6A3—brainstem—autistic disorder	0.0105	0.0332	CbGeAlD
Lisdexamfetamine—SLC6A3—forebrain—autistic disorder	0.0102	0.032	CbGeAlD
Lisdexamfetamine—SLC18A2—digestive system—autistic disorder	0.00944	0.0297	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalon—autistic disorder	0.00935	0.0294	CbGeAlD
Lisdexamfetamine—SLC6A2—brainstem—autistic disorder	0.0085	0.0268	CbGeAlD
Lisdexamfetamine—SLC6A2—forebrain—autistic disorder	0.0082	0.0258	CbGeAlD
Lisdexamfetamine—ADRA1B—head—autistic disorder	0.00777	0.0245	CbGeAlD
Lisdexamfetamine—SLC18A2—head—autistic disorder	0.0077	0.0242	CbGeAlD
Lisdexamfetamine—SLC6A2—telencephalon—autistic disorder	0.00754	0.0238	CbGeAlD
Lisdexamfetamine—ADRA1B—nervous system—autistic disorder	0.00737	0.0232	CbGeAlD
Lisdexamfetamine—SLC18A2—nervous system—autistic disorder	0.0073	0.023	CbGeAlD
Lisdexamfetamine—ADRA1B—central nervous system—autistic disorder	0.00709	0.0223	CbGeAlD
Lisdexamfetamine—SLC18A2—central nervous system—autistic disorder	0.00703	0.0221	CbGeAlD
Lisdexamfetamine—SLC18A2—cerebellum—autistic disorder	0.00687	0.0216	CbGeAlD
Lisdexamfetamine—SLC6A3—head—autistic disorder	0.00582	0.0183	CbGeAlD
Lisdexamfetamine—ADRA1B—brain—autistic disorder	0.00563	0.0177	CbGeAlD
Lisdexamfetamine—SLC18A2—brain—autistic disorder	0.00558	0.0176	CbGeAlD
Lisdexamfetamine—SLC6A3—nervous system—autistic disorder	0.00552	0.0174	CbGeAlD
Lisdexamfetamine—Phenelzine—ABAT—autistic disorder	0.0054	0.218	CrCbGaD
Lisdexamfetamine—SLC6A3—central nervous system—autistic disorder	0.00531	0.0167	CbGeAlD
Lisdexamfetamine—SLC6A3—cerebellum—autistic disorder	0.00519	0.0164	CbGeAlD
Lisdexamfetamine—SLC6A2—head—autistic disorder	0.0047	0.0148	CbGeAlD
Lisdexamfetamine—SLC6A2—nervous system—autistic disorder	0.00445	0.014	CbGeAlD
Lisdexamfetamine—SLC6A2—central nervous system—autistic disorder	0.00429	0.0135	CbGeAlD
Lisdexamfetamine—SLC6A3—brain—autistic disorder	0.00422	0.0133	CbGeAlD
Lisdexamfetamine—SLC6A2—brain—autistic disorder	0.0034	0.0107	CbGeAlD
Lisdexamfetamine—Selegiline—MAOB—autistic disorder	0.00287	0.116	CrCbGaD
Lisdexamfetamine—Phenelzine—MAOB—autistic disorder	0.00253	0.102	CrCbGaD
Lisdexamfetamine—Amphetamine—MAOB—autistic disorder	0.00239	0.0963	CrCbGaD
Lisdexamfetamine—Methamphetamine—MAOB—autistic disorder	0.00221	0.0892	CrCbGaD
Lisdexamfetamine—Selegiline—MAOA—autistic disorder	0.00201	0.0812	CrCbGaD
Lisdexamfetamine—Labetalol—ADRB2—autistic disorder	0.00197	0.0793	CrCbGaD
Lisdexamfetamine—Phenelzine—MAOA—autistic disorder	0.00177	0.0716	CrCbGaD
Lisdexamfetamine—Methamphetamine—MAOA—autistic disorder	0.00155	0.0626	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC6A4—autistic disorder	0.00108	0.0435	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC6A4—autistic disorder	0.001	0.0403	CrCbGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—TSC2—autistic disorder	0.000773	0.00118	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CHRNB2—autistic disorder	0.00077	0.00117	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—LEP—autistic disorder	0.000756	0.00115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—autistic disorder	0.00075	0.00114	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—CP—autistic disorder	0.000744	0.00113	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—autistic disorder	0.00074	0.00112	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRG3—autistic disorder	0.000739	0.00112	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—KCNMA1—autistic disorder	0.000733	0.00111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—autistic disorder	0.000726	0.0011	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—GSTP1—autistic disorder	0.000712	0.00108	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000707	0.00108	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000707	0.00108	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR5A—autistic disorder	0.000706	0.00107	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—autistic disorder	0.000702	0.00107	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—autistic disorder	0.000699	0.00106	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SLC1A3—autistic disorder	0.000699	0.00106	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIK2—autistic disorder	0.000699	0.00106	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC9A9—autistic disorder	0.000686	0.00104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—PIK3CG—autistic disorder	0.000683	0.00104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—AVPR1A—autistic disorder	0.000671	0.00102	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GAD1—autistic disorder	0.00067	0.00102	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—CP—autistic disorder	0.000659	0.001	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—HTR3A—autistic disorder	0.000658	0.001	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRG3—autistic disorder	0.000654	0.000995	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—GSTM1—autistic disorder	0.000654	0.000995	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—AVP—autistic disorder	0.000652	0.000991	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—OXT—autistic disorder	0.000643	0.000977	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GABBR1—autistic disorder	0.000639	0.000972	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—COMT—autistic disorder	0.000633	0.000963	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—GSTP1—autistic disorder	0.000631	0.000959	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC1A3—autistic disorder	0.00063	0.000959	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—AQP4—autistic disorder	0.00063	0.000959	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—MAOA—autistic disorder	0.000629	0.000956	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—OXTR—autistic disorder	0.000628	0.000954	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIA1—autistic disorder	0.000623	0.000947	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIN2A—autistic disorder	0.000623	0.000947	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—DLG4—autistic disorder	0.000601	0.000915	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GABBR2—autistic disorder	0.0006	0.000913	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CHRNB2—autistic disorder	0.00059	0.000897	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—PRKCB—autistic disorder	0.000586	0.000892	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—HTR3A—autistic disorder	0.000583	0.000887	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—GSTM1—autistic disorder	0.00058	0.000881	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVPR1A—autistic disorder	0.000575	0.000874	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—autistic disorder	0.000575	0.000874	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—GJA1—autistic disorder	0.000573	0.000871	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—autistic disorder	0.000562	0.000855	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—CP—autistic disorder	0.000562	0.000854	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC40A1—autistic disorder	0.00056	0.000851	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRA5—autistic disorder	0.00056	0.000851	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRA4—autistic disorder	0.00056	0.000851	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRB1—autistic disorder	0.00056	0.000851	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRA3—autistic disorder	0.00056	0.000851	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—autistic disorder	0.000559	0.000851	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OXTR—autistic disorder	0.000538	0.000818	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRA1—autistic disorder	0.000537	0.000816	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRB3—autistic disorder	0.000537	0.000816	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CHRNA4—autistic disorder	0.000536	0.000815	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1D—autistic disorder	0.000535	0.000813	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GRM8—autistic disorder	0.000497	0.000756	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—autistic disorder	0.000497	0.000755	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC40A1—autistic disorder	0.000496	0.000754	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRA4—autistic disorder	0.000496	0.000754	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRA5—autistic disorder	0.000496	0.000754	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRA3—autistic disorder	0.000496	0.000754	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRB1—autistic disorder	0.000496	0.000754	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—COMT—autistic disorder	0.000493	0.000749	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—autistic disorder	0.000489	0.000744	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—WNT2—autistic disorder	0.000482	0.000732	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—autistic disorder	0.000479	0.000729	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—TF—autistic disorder	0.000478	0.000726	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000476	0.000724	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000476	0.000724	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRA1—autistic disorder	0.000475	0.000723	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRB3—autistic disorder	0.000475	0.000723	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD1—autistic disorder	0.000462	0.000702	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—DLG4—autistic disorder	0.000461	0.000701	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—PRKCB—autistic disorder	0.000449	0.000683	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—autistic disorder	0.000447	0.00068	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—AVP—autistic disorder	0.00044	0.00067	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—AVP—autistic disorder	0.000439	0.000667	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—AVPR1A—autistic disorder	0.000438	0.000666	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—autistic disorder	0.000426	0.000647	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OXT—autistic disorder	0.000426	0.000647	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—autistic disorder	0.000424	0.000645	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—AQP4—autistic disorder	0.000424	0.000645	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GRM5—autistic disorder	0.000423	0.000643	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000422	0.000641	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000422	0.000641	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—OXTR—autistic disorder	0.00041	0.000623	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—SCT—autistic disorder	0.000405	0.000616	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR5A—autistic disorder	0.000399	0.000607	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD1—autistic disorder	0.000396	0.000602	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—autistic disorder	0.000394	0.000599	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—AVP—autistic disorder	0.000388	0.000591	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GABBR1—autistic disorder	0.000387	0.000588	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADM—autistic disorder	0.000387	0.000588	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—PRKCB—autistic disorder	0.000385	0.000586	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.000383	0.000583	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—CP—autistic disorder	0.000378	0.000575	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—COMT—autistic disorder	0.000377	0.000574	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—autistic disorder	0.000376	0.000571	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—AQP4—autistic disorder	0.000376	0.000571	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—MAOA—autistic disorder	0.000375	0.00057	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2A—autistic disorder	0.000367	0.000557	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—OPRM1—autistic disorder	0.000365	0.000555	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	0.000362	0.000551	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR5A—autistic disorder	0.000362	0.000551	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—PRKCB—autistic disorder	0.00035	0.000532	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GABBR2—autistic disorder	0.000339	0.000516	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—CP—autistic disorder	0.000335	0.000509	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—AVP—autistic disorder	0.000331	0.000504	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—autistic disorder	0.000328	0.000498	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1B—autistic disorder	0.000324	0.000493	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—OXT—autistic disorder	0.000324	0.000493	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—TF—autistic disorder	0.000322	0.000489	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—HRAS—autistic disorder	0.000313	0.000476	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	0.00031	0.000472	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GABBR2—autistic disorder	0.000308	0.000468	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1D—autistic disorder	0.000302	0.00046	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—MAPK1—autistic disorder	0.000302	0.000459	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD1—autistic disorder	0.000301	0.000458	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD3—autistic disorder	0.000292	0.000444	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.000292	0.000444	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—TF—autistic disorder	0.000285	0.000433	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	0.000283	0.000431	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CALCA—autistic disorder	0.000282	0.000429	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GRM8—autistic disorder	0.000281	0.000427	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1D—autistic disorder	0.000275	0.000417	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—PRKCB—autistic disorder	0.000268	0.000407	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4A—autistic disorder	0.000264	0.000402	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GRM8—autistic disorder	0.000255	0.000388	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AVPR1A—autistic disorder	0.000247	0.000376	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—WNT2—autistic disorder	0.000247	0.000376	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.000243	0.000369	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—autistic disorder	0.000243	0.000369	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4A—autistic disorder	0.00024	0.000365	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GRM5—autistic disorder	0.000239	0.000363	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—VIP—autistic disorder	0.000239	0.000363	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADRB2—autistic disorder	0.000236	0.00036	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—MAPK1—autistic disorder	0.000231	0.000352	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—OXTR—autistic disorder	0.000231	0.000352	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—SCT—autistic disorder	0.000229	0.000348	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AVPR1A—autistic disorder	0.000225	0.000342	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NRP2—autistic disorder	0.000223	0.000339	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—AVP—autistic disorder	0.000223	0.000339	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—AVP—autistic disorder	0.000222	0.000338	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADM—autistic disorder	0.000219	0.000332	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GABBR1—autistic disorder	0.000219	0.000332	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—VIP—autistic disorder	0.000217	0.00033	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GRM5—autistic disorder	0.000217	0.00033	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR5A—autistic disorder	0.000214	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4B—autistic disorder	0.000213	0.000324	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—OXTR—autistic disorder	0.00021	0.00032	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—SCT—autistic disorder	0.000208	0.000316	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—OPRM1—autistic disorder	0.000206	0.000314	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GABBR1—autistic disorder	0.000198	0.000302	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADM—autistic disorder	0.000198	0.000302	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—AVP—autistic disorder	0.000197	0.0003	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000194	0.000295	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4B—autistic disorder	0.000193	0.000294	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—OPRM1—autistic disorder	0.000187	0.000285	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—HRAS—autistic disorder	0.000186	0.000283	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2A—autistic disorder	0.000185	0.000281	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—OXT—autistic disorder	0.000183	0.000278	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1B—autistic disorder	0.000183	0.000278	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GABBR2—autistic disorder	0.000182	0.000277	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—autistic disorder	0.00018	0.000274	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD1—autistic disorder	0.00017	0.000259	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1B—autistic disorder	0.000166	0.000253	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—OXT—autistic disorder	0.000166	0.000253	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD3—autistic disorder	0.000165	0.000251	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1D—autistic disorder	0.000162	0.000247	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL5—autistic disorder	0.000161	0.000245	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CALCA—autistic disorder	0.000159	0.000242	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRLR—autistic disorder	0.000156	0.000237	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD1—autistic disorder	0.000155	0.000235	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GRM8—autistic disorder	0.000151	0.000229	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD3—autistic disorder	0.00015	0.000228	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000148	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—POMC—autistic disorder	0.000148	0.000224	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL5—autistic disorder	0.000147	0.000223	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—WNT2—autistic disorder	0.000146	0.000222	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CALCA—autistic disorder	0.000145	0.00022	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—autistic disorder	0.000145	0.00022	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GHR—autistic disorder	0.000144	0.000219	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4A—autistic disorder	0.000142	0.000216	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—MAPK1—autistic disorder	0.000138	0.00021	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRB2—autistic disorder	0.000134	0.000203	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AVPR1A—autistic disorder	0.000133	0.000202	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VIP—autistic disorder	0.000128	0.000195	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GRM5—autistic disorder	0.000128	0.000195	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AVP—autistic disorder	0.000126	0.000191	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OXTR—autistic disorder	0.000124	0.000189	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SCT—autistic disorder	0.000123	0.000187	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB2—autistic disorder	0.000121	0.000184	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000119	0.000181	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GABBR1—autistic disorder	0.000117	0.000178	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADM—autistic disorder	0.000117	0.000178	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EIF4E—autistic disorder	0.000115	0.000175	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4B—autistic disorder	0.000114	0.000174	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AVP—autistic disorder	0.000114	0.000173	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000114	0.000173	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—HRAS—autistic disorder	0.000111	0.000168	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OPRM1—autistic disorder	0.000111	0.000168	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PLA2G4A—autistic disorder	0.000107	0.000163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2A—autistic disorder	0.000104	0.000159	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GZMB—autistic disorder	0.000101	0.000154	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1B—autistic disorder	9.83e-05	0.000149	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OXT—autistic disorder	9.83e-05	0.000149	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2A—autistic disorder	9.49e-05	0.000144	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCB—autistic disorder	9.16e-05	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD1—autistic disorder	9.13e-05	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TSC1—autistic disorder	9.13e-05	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NTRK2—autistic disorder	8.89e-05	0.000135	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD3—autistic disorder	8.85e-05	0.000135	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PIK3CG—autistic disorder	8.76e-05	0.000133	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL5—autistic disorder	8.66e-05	0.000132	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CALCA—autistic disorder	8.55e-05	0.00013	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—POMC—autistic disorder	8.34e-05	0.000127	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCB—autistic disorder	8.32e-05	0.000126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PIK3CG—autistic disorder	7.96e-05	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—POMC—autistic disorder	7.58e-05	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRL—autistic disorder	7.56e-05	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB2—autistic disorder	7.17e-05	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AVP—autistic disorder	6.73e-05	0.000102	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IGF2—autistic disorder	6.7e-05	0.000102	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLA2G4A—autistic disorder	6.33e-05	9.63e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL2—autistic disorder	6.17e-05	9.38e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MEF2C—autistic disorder	6.16e-05	9.37e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITGB3—autistic disorder	6e-05	9.13e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	5.6e-05	8.52e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL2—autistic disorder	5.6e-05	8.52e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TSC2—autistic disorder	5.32e-05	8.09e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOE—autistic disorder	5.21e-05	7.92e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LEP—autistic disorder	5.21e-05	7.92e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	4.91e-05	7.47e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APC—autistic disorder	4.7e-05	7.15e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	4.7e-05	7.15e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EGF—autistic disorder	4.65e-05	7.07e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—POMC—autistic disorder	4.48e-05	6.8e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IGF1—autistic disorder	4.3e-05	6.55e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	4.28e-05	6.51e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	4.09e-05	6.22e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	3.44e-05	5.23e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL2—autistic disorder	3.31e-05	5.03e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6—autistic disorder	3.29e-05	5.01e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PTEN—autistic disorder	3.11e-05	4.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	2.53e-05	3.85e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HRAS—autistic disorder	2.03e-05	3.09e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6—autistic disorder	1.94e-05	2.96e-05	CbGpPWpGaD
